Regent Pacific Group Limited (FRA:RPG)

Market Cap	31.45M +194.1%
Revenue (ttm)	709.30K +535.9%
Net Income	-3.47M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	106
Open	0.1030
Previous Close	0.1040
Day's Range	0.1030 - 0.1030
52-Week Range	0.0350 - 0.1270
Beta	n/a
RSI	50.19
Earnings Date	Mar 27, 2026

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Investors, not elsewhere classified
• Founded: 1991
• Employees: 17
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RPG

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.

Financial numbers in USD